Cornerstone Advisors, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cornerstone Advisors, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2019$128,000
+19.6%
1,405
+26.2%
0.01%
+9.1%
Q1 2019$107,000
+78.3%
1,113
+57.9%
0.01%0.0%
Q4 2018$60,000
+39.5%
705
+40.4%
0.01%
-60.7%
Q3 2018$43,000
+115.0%
502
+89.4%
0.03%
+100.0%
Q2 2018$20,000
-25.9%
265
-19.5%
0.01%
-22.2%
Q1 2018$27,000
+17.4%
329
+20.5%
0.02%
+20.0%
Q4 2017$23,000
+9.5%
273
+11.9%
0.02%
+7.1%
Q3 2017$21,000
+10.5%
244
+6.6%
0.01%
+27.3%
Q2 2017$19,000
+171.4%
229
+138.5%
0.01%
+175.0%
Q1 2017$7,0000.0%960.0%0.00%
-33.3%
Q4 2016$7,000
-79.4%
96
-77.7%
0.01%
-79.3%
Q3 2016$34,000
-5.6%
430
-2.7%
0.03%
-21.6%
Q2 2016$36,000
+20.0%
442
+5.7%
0.04%
+15.6%
Q1 2016$30,000
-25.0%
418
-11.1%
0.03%
-27.3%
Q4 2015$40,000
-9.1%
470
-2.3%
0.04%
+12.8%
Q3 2015$44,000
-6.4%
481
+1.3%
0.04%
+2.6%
Q2 2015$47,0000.0%4750.0%0.04%
+5.6%
Q1 2015$47,000
+6.8%
475
+1.1%
0.04%
+12.5%
Q4 2014$44,000
+25.7%
470
+25.7%
0.03%
+10.3%
Q3 2014$35,000
+2.9%
3740.0%0.03%
-9.4%
Q2 2014$34,000
+6.2%
374
-1.3%
0.03%
-15.8%
Q1 2014$32,000
-30.4%
379
-34.1%
0.04%
-41.5%
Q4 2013$46,000
+4.5%
5750.0%0.06%
-14.5%
Q3 2013$44,000
+7.3%
5750.0%0.08%
-24.8%
Q2 2013$41,0005750.10%
Other shareholders
NOVARTIS A G shareholders Q3 2017
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders